Flash FinanceUS
Pre-market S&P 5007,376.86+0.31% Nasdaq24,579.42+1.09% Dow 3051,285.73-0.46% Russell 20002,754.11+0.89% Nasdaq-10026,989.99+1.35% MidCap 4003,602.50+0.56% SmallCap 6001,673.98+0.05% VIX25.64-9.01% 10Y Yield4.86+0.45% Close of Nov 06, 2026
AI brief of an SEC Form 8-K · Merit Medical Systems (MMSI)

Merit Medical names Sheri Lewis EVP of Global Operations; COO role eliminated

Neutral Impact 4 of 5 leadership Written later

Merit Medical said it eliminated its Chief Operating Officer position in an August 14, 2026 reorganization and named Sheri Lewis Executive Vice President of Global Operations, effective August 31, 2026. Neil W. Peterson, the former COO, became Senior Advisor and has given notice of resignation for good reason effective March 5, 2027. The filing describes a leadership change in the operations function without any reported financial results.

Key points

  • Sheri Lewis appointed EVP of Global Operations effective August 31, 2026, with a $600,000 base salary and $400,000 signing bonus
  • Lewis's target annual bonus is 60% of base salary, with a maximum of 200%
  • Neil W. Peterson's COO title was changed to Senior Advisor; his resignation takes effect March 5, 2027
  • Lewis's agreement provides a lump sum of two times salary plus bonus average if terminated without cause or for good reason after a change of control

The filing

CompanyMerit Medical Systems (MMSI)
Form8-K, current report
Filed with the SECAug 20, 2026, 4:02 PM ET
Accession number0000856982-26-000047

Items reported: 5.02 Director / Officer Change7.01 Regulation FD Disclosure

Read the filing on SEC.gov ↗

Written by AI on Nov 8, 2026, 1:05 AM ET, from this filing only. Written later: this filing was briefed after the fact, when past filings were added to the site, so the brief may be read with hindsight; the filing itself is the record of what was known on August 20, 2026.

Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.